🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07002372
Recruiting Not applicable

Effect of Video Viewing on Intravitreal Injection Experience

NCT07002372 · tracked via the Priya Life Science China tracker
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase
Not applicable
Started
2025-05-05
Last updated
2025-06-03

Condition(s) studied

Age Related Macular DegenerationDiabetic RetinopathyChoroidal NeovascularizationRetinal Vein OcclusionCystoid Macular Edema

Investigational drug(s) / intervention(s)

Procedure video viewing

Procedure video viewing: Patients who have never had an intravitreal injection before will be randomly assigned to watch an educational video about the procedure prior to treatment.

Study summary

Study Objective The goal of this clinical trial is to evaluate whether viewing a procedural video can improve the patient experience and reduce the incidence and severity of subconjunctival hemorrhage in individuals undergoing intravitreal anti-VEGF injections.

Key Research Questions

1. Can viewing the procedural video prior to treatment reduce the rate and/or area of subconjunctival hemorrhage?
2. Can the video improve the patient experience, specifically by reducing anxiety levels and increasing satisfaction with the treatment process?

Study Design Participants will be randomly assigned to either an intervention group, who will watch an educational video explaining the injection procedure, or a control group, who will not view the video.

All participants will complete the State-Trait Anxiety Inventory-State (STAI-S) questionnaire both before and after treatment to assess changes in anxiety levels.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Patients who are receiving their first intravitreal injection of anti-VEGF medication due to retinal diseases * Mentally competent, and able to communicate without barriers * Willing to voluntarily sign an informed consent form. Exclusion Criteria: * History of previous eye surgery * Best-corrected visual acuity in the better eye worse than 0.3 * The target eye is complicated with neovascular glaucoma.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou Zhejiang Recruiting

More Second Affiliated Hospital, Zhejiang University, School of Medicine trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07002372 on ClinicalTrials.gov ↗ ← All trials in China